Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07TRV
|
||||
| Former ID |
DIB007233
|
||||
| Drug Name |
Anthrax vaccine
|
||||
| Synonyms |
Anthrax vaccine, DynPort/AVANT; Injectable anthrax vaccine, DynPort/AVANT; Anthrax vaccine (injectable), DynPort/AVANT
|
||||
| Drug Type |
Vaccine
|
||||
| Indication | Bacillus anthracis infection [ICD10:A22] | Discontinued in Phase 1 | [1] | ||
| Company |
Celldex Therapeutics Inc
|
||||
| Target and Pathway | |||||
| Target(s) | Protective antigen | Target Info | [2] | ||
| Pathway Interaction Database | Cellular roles of Anthrax toxin | ||||
| Reactome | Uptake and function of anthrax toxins | ||||
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017549) | ||||
| REF 2 | Annual Reports in Medicinal Chemistry. Annette M. Doherty. 2005. Page(214). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.